Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America ·Vol. 31 ·No. 3 ·2000-09-00 ·Pages E7-8

Receveur MC, Thiébaut R, Vedy S, Malvy D, Mercié P, Bras ML

Abstract

Yellow fever vaccine (17D, a live attenuated virus vaccine) was effective and safe in 2 human immunodeficiency virus-infected patients without severe immunosuppression, one of whom traveled to Kenya and the other of whom traveled to Senegal.

MeSH Terms

Adult CD4 Lymphocyte Count Female HIV Infections/immunology,virology HIV-1 Humans Male Yellow Fever/prevention & control Yellow Fever Vaccine/administration & dosage Yellow fever virus/immunology

Chemicals

Yellow Fever Vaccine

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Receveur M C

Department of Internal Medicine, Infectious and Tropical Diseases, Hospital Saint André, Bordeaux, France. marie-catherine. receveur@chu-bordeaux.fr

Thiébaut R

Vedy S

Malvy D

Mercié P

Bras M L

Article Info

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Abbr.

Clin Infect Dis

ISSN

1058-4838

DOI

10.1086/314031

receveur@chu-bordeaux.fr

Published

2000-09-00

Pages

E7-8

Language

English

Region

United States

NLM ID

9203213

Subset

External Links

PubMed source DOI: 10.1086/314031 View journal details

Analysis Services

Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.

Contact

WeChat Official Account